The largest database of trusted experimental protocols

Dual luciferase reporter assay system

Manufactured by GenePharma
Sourced in China

The Dual-Luciferase Reporter Assay System is a laboratory equipment used for the quantitative measurement of two different luciferase reporter enzymes within a single sample. It provides a reliable and sensitive method for analyzing gene expression and regulatory elements.

Automatically generated - may contain errors

6 protocols using dual luciferase reporter assay system

1

Detailed Biochemical Assays for Liver Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver tissue was pretreated with NP-40 lysate, the samples were dissolved in assay buffer and vortexed extensively for 2 min as described previously [27 (link)], and then, TG content was determined according to the manufacturer’s instruction (Abcam, Cambridge, UK). The luciferase activity assay was carried out using the Dual-Luciferase Reporter Assay System (GenePharma, Shanghai, China). HEK293T cells were cotransfected with miR-743a-3p mimic/inhibitor and GSTM1-3′-UTR reporter. Luciferase activity was evaluated 48 h after transfection, as described previously [28 (link)]. The coimmunoprecipitation (co-IP) assay was performed as Sun, et al. described [29 (link)]. In brief, cells were lysed in co-IP buffer on ice for 30 min. Then, the cells were centrifuged, and the supernatant was collected, followed by incubation with Flag Magnetic Beads (Sigma-Aldrich, St. Louis, MO) with gentle rocking overnight at 4 °C. The mixture pelleted was washed three times and then eluted in a loaded buffer and denatured at 95 °C for 10 min before western blotting. The reagents and methods for malonaldehyde (MDA), GST activity, mRNA and protein expression, immunohistochemistry, and immunofluorescence are detailed in Additional file 1.
+ Open protocol
+ Expand
2

Luciferase Assay for BUB1B Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT or mutated BUB1B-promoter was cloned into the pGL3-Luc reporter vector (Genepharma, Shanghai). LUAD cell lines were plated into 24-well plates and transfected with ZNF143 plasmids using Lipofectamine 2000 (Invitrogen, Waltham, MA, USA) after 24 h. After 48 h, luciferase activity was measured by using the Dual-Luciferase reporter assay system(Genepharma, Shanghai) as the manufacturer’s instructions [20 (link)].
+ Open protocol
+ Expand
3

Regulation of Ednra Gene by miR-1929-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length 3′-UTR of the endothelin A receptor (Ednra) gene was amplified by PCR and cloned downstream the pmirGLO Luciferase (Shanghai GenePharma Co., Ltd, China) multiple cloning site by digestion with the SpeI and HindIII restriction enzymes. The resulting construct was called pEdnra-wild-type (Wt). The miR-1929-3p binding site on the Ednra mRNA was mutated and cloned in the pmirGLO Luciferase plasmid to create the pEdnra-Mutant (Mut) vector. The Wt and Mut vectors were each transfected with and without miR-1929-3p into the HEK293 cells. Additionally, a dual-luciferase reporter gene assay was performed using the dual-luciferase reporter assay system (Shanghai GenePharma Co., Ltd, China).
The mmu-miR-1929-3p mimics, corresponding negative control and siRNA targeting Ednra were synthesized from GenePharma (Shanghai GenePharma Co., Ltd, China). Ednra sense 5′-CCTGGCAGGAAACAATGTCAAAGTGGCCAAATGAGCTGATTGTGTTAAGTGAGATGTAGTTACACC-3′ antisense 5′-TCGAGGTGTAACTACATCTCACTTAACACAATCAGCTCATTTGGCCACTTTGACATTGTTTCCTGCCAGGAGCT-3′; si-Ednra sense 5′-CGCAGAACAUCAAAGAAGATT-3′, antisense 5′-UCUUCUUUGAUGUUCUGCGTT-3′; negative control siRNA sense 5′-UUCUCCGAACGUGUCACGUTT-3′, antisense 5′-ACGUGACACGUUCGGAGAATT-3′.
+ Open protocol
+ Expand
4

Validating NRAS-miR-181a-5p Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NRAS sequence was amplified and inserted into the plucGLO plasmid (Promega, Fitchburg, WI, USA) downstream of the luciferase gene to obtain the Wild-Type (WT) reporter pmir-NRAS-WT. To obtain the Mutant (MUT) luciferase reporter pmir-NRAS-MUT, the putative binding site for miR-181a-5p in the NRAS sequence was mutated using the GeneArt™ Site-Directed Mutagenesis PLUS System (cat. no. A14604; Thermo Fisher Scientific, Inc., Waltham, MA, USA). pmir-NRAS-WT, pmir-NRAS-MUT, and miR-181a-5p mimics and mimic-NC were co-transfected into SO-Rb50 or Y79 cells using Lipofectamine® 3000 (Invitrogen, Carlsbad, CA, USA). Then, 48h after transfection, the luciferase activity of the cells in each group was analyzed using the Dual-Luciferase Reporter Assay System (GenePharma, Shanghai, China). The firefly luciferase activity in each group was detected, and Renilla luciferase activity was used as a control.
+ Open protocol
+ Expand
5

Dual-Luciferase Reporter Assay for miR-338-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type or mutant NEAT1_1 or 3’-untranslated region (UTR) of AKR1C1 containing the predicted binding sites of miR-338-3p were designed and synthesized by GenePharma (Shanghai, China). The luciferase activity of firefly luciferase and Renilla luciferase was measured using a dual-luciferase reporter assay system (GenePharma) according to the manufacturer’s instructions. The firefly luciferase was used as internal control to normalize the Renilla luciferase. All transfection assays were carried out in triplicate.
+ Open protocol
+ Expand
6

EFNB2 3'UTR Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HTR-8/SVneo cells were used for a dual-luciferase reporter gene assay. EFNB2 3′-UTR (EFNB2-wt) and mutated EFNB2 3′-UTR (EFNB2-mut) were constructed by GenePharma and luciferase activity was tested using the Dual-Luciferase Reporter Assay System (cat. no. E1910; Promega, Madison, USA) with Renilla luciferase activity as a normalized control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!